Person using the MyWay Diabetes app in a bright NHS waiting room, demonstrating the app's Target Chart during everyday diabetes self-management.

MyWay Diabetes

MyWay Diabetes achieves 95% ORCHA score and highest ranking on the platform

MyWay Diabetes has achieved a 95% ORCHA Baseline Review score and, at the time of publication, is the highest-scoring app listed on the ORCHA platform.

The independent assessment evaluates digital health products across areas including clinical assurance, data privacy and security, accessibility, usability and professional assurance.

For healthcare organisations, this provides additional assurance that MyWay Diabetes has been independently assessed against recognised standards in some of the areas that matter most when adopting digital health technology.

At a glance

ORCHA Baseline Review score

95%

Ranking at time of publication

Highest-scoring app on the ORCHA platform*

Assessment areas

Clinical assurance, data privacy and security, accessibility, usability and professional assurance

*Highest-scoring app listed on the ORCHA platform at the time of publication.

MyWay Diabetes ORCHA recognition graphic showing a 95% ORCHA Baseline Review score.

Built for real-world healthcare

MyWay Diabetes has been developed in collaboration with people living with diabetes, clinicians and healthcare organisations, with clinical governance, accessibility and user feedback embedded throughout its development.

The platform combines digital self-management support, structured education, personalised information and health data to help people better understand and manage their condition.

While the ORCHA assessment relates specifically to MyWay Diabetes, it reflects the standards we apply across the development and delivery of our digital health services.

From diabetes to wider cardiometabolic health

MyWay Digital Health now supports population-scale digital pathways across:

  • Diabetes
  • Diabetes prevention and remission
  • Weight management
  • Cardiovascular disease and cardiovascular risk
  • Hypertension

What comes next

Achieving a 95% ORCHA score is an important milestone, but maintaining those standards matters just as much.

We will continue to develop MyWay around clinical evidence, user need and the requirements of the healthcare organisations we work with, while expanding our support across cardiometabolic health.

About MyWay Digital Health

MyWay Digital Health develops digital solutions for the prevention and management of cardiometabolic disease, working with healthcare organisations in the UK and internationally.

Our technology supports people to better understand and manage their health while helping healthcare systems deliver more personalised, scalable care.